Bladder cancer: surgery vs. chemo-radiation
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares two main treatments for muscle-invasive bladder cancer: radical cystectomy (surgery to remove the bladder) and a combination of chemotherapy and radiation (chemo-radiation). The goal is to see which approach is better for patients whose cancer has not spread widely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- Your bladder cancer is mostly a type called urothelial carcinoma, and it has invaded the muscle layer (stages T2, T3, or T4a) but has not spread to distant organs.
- You are generally well enough to perform daily activities (ECOG performance status 0 or 1).
- You have good kidney function (GFR over 40) and adequate blood counts (neutrophils, platelets, hemoglobin).
- You are able to receive cisplatin-based chemotherapy before starting the study treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of chemotherapy, immunotherapy, and radiation to treat muscle-invasive bladder cancer while trying to avoid bladder removal. It compares this approach to a watch-and-wait strategy, and also looks at adding maintenance immunotherapy.
This study looks at how well MRI scans can detect bladder cancer after chemotherapy, before surgery to remove the bladder. It may help doctors know if the chemo is working.
This Phase 2 study tests whether adding chemotherapy and immunotherapy along with targeted pelvic radiation after bladder tumor surgery can reduce bladder cancer returning or spreading. It focuses on people with non-metastatic, muscle-invasive urothelial bladder cancer.
This trial tests a dense schedule of two chemotherapy drugs (gemcitabine and cisplatin) given before bladder removal surgery. It aims to shrink the tumor and improve outcomes for people with bladder cancer that has grown into the muscle layer.
This trial tests whether removing part of the bladder (partial cystectomy) along with standard chemotherapy or immunotherapy before surgery is effective for people with a specific type of bladder cancer that hasn't spread beyond the bladder.
This study looks at how well a standard chemotherapy given before surgery works for muscle-invasive bladder cancer. It aims to see if higher responses lead to better outcomes.
Hear when a new Muscle Invasive Bladder Cancer (MIBC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.